Histamine H2 receptor antagonists.
D000249:Adenosine Monophosphate / Q000378:metabolism; D000380:Agranulocytosis / Q000209:etiology; D000707:Anaphylaxis / Q000139:chemically induced; D000818:Animals; D000941:Antigens / Q000009:adverse effects / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002628:Chemoreceptor Cells / Q000187:drug effects; D002744:Chlorpheniramine / Q000494:pharmacology; D004285:Dogs; D005750:Gastric Juice / Q000378:metabolism; D006168:Guinea Pigs; D006331:Heart Diseases / Q000139:chemically induced; D006632:Histamine / Q000378:metabolism / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000138:chemical synthesis / Q000145:classification / Q000494:pharmacology / Q000592:standards / Q000627:therapeutic use / Q000633:toxicity; D006801:Humans; D006967:Hypersensitivity / Q000097:blood; D007962:Leukocytes / Q000378:metabolism; D010406:Penicillins / Q000276:immunology
D000941:Antigens; D006634:Histamine H1 Antagonists; D010406:Penicillins; D002744:Chlorpheniramine; D000249:Adenosine Monophosphate; D006632:Histamine